Pentoxifylline was initially marketed for use in patients with intermittent claudication due to chronic occlusive arterial disease of the extremities but has since been shown to have several off-label uses. It can be described chemically as 1-(5-oxohexyl)-3, 7-dimethylxanthine, which is a tri-substituted xanthine derivative. 1 Pentoxifylline has a variety of mechanisms of action (Figure 1). In its original purpose, it was used because of its rheological modifying properties, such as increasing the deformability of erythrocytes